MASS PRODUCT-LIABILITY LITIGATION

[1] ATKINSON MH, 1980, J RHEUMATOL, V7, P109

[2] BIRD HA, 1980, J RHEUMATOL, V7, P139

[3] PHARMACOLOGY OF BENOXAPROFEN (2-[4-CHLOROPHENYL]-ALPHA-METHYL-5-BENZOXAZOLE ACETIC-ACID), LRCL-3794, A NEW COMPOUND WITH ANTI-INFLAMMATORY ACTIVITY APPARENTLY UNRELATED TO INHIBITION OF PROSTAGLANDIN SYNTHESIS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 330 - 336

[4] SETTLEMENT OF THE BENOXAPROFEN CASE [J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6615) : 109 - 110

[5] FIRTH H, 1982, BRIT MED J, V284, P1784, DOI 10.1136/bmj.284.6331.1784

[6] GOUDIE BM, 1982, LANCET, V1, P959

[7] BENOXAPROFEN - SIDE-EFFECT PROFILE IN 300 PATIENTS [J]. BMJ-BRITISH MEDICAL JOURNAL, 1982, 284 (6326): : 1365 - 1368

[8] SIDE-EFFECTS OF BENOXAPROFEN [J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6326) : 1368 - 1369

[9] PRESCRIPTION-EVENT MONITORING [J]. BRITISH MEDICAL JOURNAL, 1982, 285 (6344) : 809 - 810

[10] LAURENCE DR, 1983, BR MED J, V286, P218

[1] ATKINSON MH, 1980, J RHEUMATOL, V7, P109

[2] BIRD HA, 1980, J RHEUMATOL, V7, P139

[3] PHARMACOLOGY OF BENOXAPROFEN (2-[4-CHLOROPHENYL]-ALPHA-METHYL-5-BENZOXAZOLE ACETIC-ACID), LRCL-3794, A NEW COMPOUND WITH ANTI-INFLAMMATORY ACTIVITY APPARENTLY UNRELATED TO INHIBITION OF PROSTAGLANDIN SYNTHESIS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 330 - 336

[4] SETTLEMENT OF THE BENOXAPROFEN CASE [J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6615) : 109 - 110

[5] FIRTH H, 1982, BRIT MED J, V284, P1784, DOI 10.1136/bmj.284.6331.1784

[6] GOUDIE BM, 1982, LANCET, V1, P959

[7] BENOXAPROFEN - SIDE-EFFECT PROFILE IN 300 PATIENTS [J]. BMJ-BRITISH MEDICAL JOURNAL, 1982, 284 (6326): : 1365 - 1368

[8] SIDE-EFFECTS OF BENOXAPROFEN [J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6326) : 1368 - 1369

[9] PRESCRIPTION-EVENT MONITORING [J]. BRITISH MEDICAL JOURNAL, 1982, 285 (6344) : 809 - 810

[10] LAURENCE DR, 1983, BR MED J, V286, P218